Celgene Corporation

Registered Principal Details

Cessation Date
4/23/2014 12:00:00 AM

Business Or Interest:
Biopharmaceutical company.

Lobbying Interests:
Health care access to pharmaceuticals, biotechnology issues, and cancer drug repository programs.

CEO Name:
Bob Hugin
Director of State Government Relations

Contact
HF
Helen Fitzpatrick
86 Morris Ave
Summit, NJ 07901
(312) 330-2884
jmannion@skadden.com
http://www.celgene.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Greg Chesmore Exclusive Duties N/A Authorized On 5/21/2013 Withdrawn On 4/23/2014
Kelly McDowell Exclusive Duties N/A Authorized On 5/21/2013 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 392
Assembly Bill 392
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)

Bill Text and History

For
Notification Date
9/30/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 300
Senate Bill 300
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)

Bill Text and History

2013 Wisconsin Act 186

For
Notification Date
9/17/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Access to Oral Anticancer Medications
Development, drafting or introduction of a proposal relating to
Access to Oral Anticancer Medications

Action Intended To Affect
Legislative matter

Notification Date
5/23/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
Total Lobbying Expenditures 2013
January - June
$21,739.97
2013
July - December
$26,912.27
2014
January - June
$20,938.91
2014
July - December
$251.88
Total $69,843.02
Total Hours Communicating 2013
January - June
41.25
2013
July - December
51.50
2014
January - June
29.00
2014
July - December
0.00
Total 121.75
Total Hours Other 2013
January - June
92.50
2013
July - December
128.75
2014
January - June
117.25
2014
July - December
4.00
Total 342.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
42%
2014
January - June
50%
2014
July - December
Total 32%
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
2013
July - December
58%
2014
January - June
2014
July - December
Total 23%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2013
January - June
2013
July - December
2014
January - June
2014
July - December
Total
2013
January - June
100%
2013
July - December
2014
January - June
50%
2014
July - December
100%
Total 45%

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures